Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
54,053,214
-
Total 13F shares
-
53,790,468
-
Share change
-
-613,451
-
Total reported value
-
$494,909,996
-
Put/Call ratio
-
7.7%
-
Price per share
-
$9.20
-
Number of holders
-
127
-
Value change
-
-$1,273,452
-
Number of buys
-
63
-
Number of sells
-
61
Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) as of Q3 2025
As of 30 Sep 2025,
Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,790,468 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, TCG Crossover Management, LLC, Nantahala Capital Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Balyasny Asset Management L.P., D. E. Shaw & Co., Inc., and DIMENSIONAL FUND ADVISORS LP.
This page lists
127
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.